High-Density Lipoprotein Processing and Premature Cardiovascular Disease

Area of Science:

• Cardiovascular Science
• Lipid Metabolism

Background:

• High plasma low-density lipoprotein cholesterol (LDL-C) is a known cardiovascular disease (CVD) risk factor, effectively managed by statins.
• The protective role of high-density lipoproteins (HDL) against atherosclerotic vascular disease remains controversial despite acknowledged inverse correlation with CVD.
• Impaired reverse cholesterol transport (RCT), a key function of HDL, is observed in CVD patients.

Purpose of the Study:

• To review the function of HDL in supporting reverse cholesterol transport (RCT).
• To elucidate the role of RCT in the prevention of cardiovascular disease (CVD).

Main Methods:

• Literature review of studies on HDL function, RCT mechanisms, and CVD prevention.
• Analysis of population studies examining RCT impairment in CVD patients.

Main Results:

• HDL is crucial for RCT, the process of removing cholesterol from arteries.
• RCT impairment is a characteristic feature in individuals with CVD.
• Interventions to increase HDL-C have not consistently reduced CVD risk, suggesting complexity beyond simple correlation.

Conclusions:

• HDL's role in CVD prevention is intricately linked to its function in RCT.
• Understanding HDL-mediated RCT mechanisms is vital for developing effective CVD prevention strategies.
• Further research is needed to clarify the therapeutic potential of targeting HDL and RCT.